Lipoprotein receptors, macrophages, and sphingomyelinase

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 12, 2000, Pages 2509-2510

  Kraemer, F B ^a   Suzuki, J ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN E; CD36 ANTIGEN; CERAMIDE; CHOLESTEROL ESTER; CHONDROITIN ABC LYASE; GLYCOSAMINOGLYCAN; LIPOPROTEIN LIPASE; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PHOSPHORYLCHOLINE; SCAVENGER RECEPTOR; SPHINGOMYELIN PHOSPHODIESTERASE; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; DISEASE MODEL; HYDROLYSIS; KNOCKOUT MOUSE; LIPID STORAGE; LIPID TRANSPORT; MACROPHAGE; MOUSE; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033675318     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.12.2509     Document Type: Review

References (18)

1. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis
2. The low-density lipoprotein receptor gene family: Multiple roles in lipid metabolism
3. Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages
4. A macrophage receptor for apolipoprotein B48: Cloning, expression, and atherosclerosis
5. Recent progress in defining the role of scavenger receptors in lipid transport, atherosclerosis and host defence
6. Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated
7. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins
8. Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles: Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans
9. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo: Molecular size as a determinant of fractional loss from the intima-inner media
10. Macrophage-released proteoglycans enhance LDL aggregation: Studies in aorta from apolipoprotein E-deficient mice
11. Enhanced macrophage uptake of low density lipoprotein after self-aggregation
12. Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition
13. Phagocytosis of aggregated lipoprotein by macrophages: Low density lipoprotein receptor-dependent foam-cell formation
14. Aggregated low density lipoprotein induces and enters surface-connected compartments of human monocytemacrophages: Uptake occurs independently of the low density lipoprotein receptor
15. Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation
16. Signalling sphingomyelinases: Which, where, how and why?
17. 2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene
18. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH: Implications for atherosclerotic lesion development